A deployment safety case for AI-assisted prostate cancer diagnosis
Open Access
- 8 May 2025
- journal article
- Published by Elsevier in Computers in Biology and Medicine
- Vol. 192 (Pt B) , 110237
Abstract
No abstract availableKeywords
Funding Information
- National Institute for Health and Care Research
- University of York
- Lloyd's Register Foundation
- NIHR Oxford Biomedical Research Centre
- Department of Health and Social Care (AI_AWARD02269)
This publication has 26 references indexed in Scilit:
- FDA-regulated AI Algorithms: Trends, Strengths, and Gaps of Validation StudiesAcademic Radiology, 2022
- A deep learning system for prostate cancer diagnosis and grading in whole slide images of core needle biopsiesScientific Reports, 2022
- An independent assessment of an artificial intelligence system for prostate cancer detection shows strong diagnostic accuracyLaboratory Investigation, 2021
- Diagnostic Accuracy and Failure Mode Analysis of a Deep Learning Algorithm for the Detection of Intracranial HemorrhageJournal of the American College of Radiology, 2021
- Impact of rescanning and normalization on convolutional neural network performance in multi-center, whole-slide classification of prostate cancerScientific Reports, 2020
- Controversial issues in Gleason and International Society of Urological Pathology (ISUP) prostate cancer grading: proposed recommendations for international implementationPathology, 2019
- Clinical-grade computational pathology using weakly supervised deep learning on whole slide imagesNature Medicine, 2019
- Automated Gleason grading of prostate cancer tissue microarrays via deep learningScientific Reports, 2018
- Prostate cancer grading: a decade after the 2005 modified systemLaboratory Investigation, 2018
- An Update of the Gleason Grading SystemJournal of Urology, 2010